17,550 Shares in The Pennant Group, Inc. $PNTG Purchased by Kings Path Partners LLC

Posted by Geri Gentry on Oct 22nd, 2026

Kings Path Partners LLC bought a new position in shares of The Pennant Group, Inc. (NASDAQ:PNTG – Free Report) during the 3rd quarter, Holdings Channel reports. The institutional investor bought 17,550 shares of the company’s stock, valued at approximately $684,000.

A number of other institutional investors have also recently bought and sold shares of PNTG. Pinnacle Associates Ltd. increased its position in shares of The Pennant Group by 3.5% during the third quarter. Pinnacle Associates Ltd. now owns 38,594 shares of the company’s stock worth $1,505,000 after acquiring an additional 1,313 shares in the last quarter. Nisa Investment Advisors LLC raised its holdings in shares of The Pennant Group by 45.4% during the third quarter. Nisa Investment Advisors LLC now owns 3,413 shares of the company’s stock worth $133,000 after acquiring an additional 1,065 shares during the period. Counterpoint Mutual Funds LLC bought a new stake in The Pennant Group in the 3rd quarter valued at $940,000. GAMMA Investing LLC lifted its position in The Pennant Group by 36.1% in the 3rd quarter. GAMMA Investing LLC now owns 2,134 shares of the company’s stock valued at $83,000 after acquiring an additional 566 shares in the last quarter. Finally, Squarepoint Ops LLC lifted its position in The Pennant Group by 62.1% in the 2nd quarter. Squarepoint Ops LLC now owns 46,785 shares of the company’s stock valued at $1,729,000 after acquiring an additional 17,916 shares in the last quarter. Institutional investors own 85.88% of the company’s stock.

The Pennant Group Stock Performance

Shares of PNTG opened at $41.04 on Thursday. The stock has a market capitalization of $1.43 billion, a price-to-earnings ratio of 37.71, a PEG ratio of 2.70 and a beta of 1.25. The Pennant Group, Inc. has a 12 month low of $22.25 and a 12 month high of $42.74. The firm has a fifty day simple moving average of $39.52 and a 200 day simple moving average of $36.73. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.48.

The Pennant Group (NASDAQ:PNTG – Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.33 by $0.03. The Pennant Group had a net margin of 2.93% and a return on equity of 10.33%. The firm had revenue of $297.98 million for the quarter, compared to analysts’ expectations of $288.71 million. The Pennant Group has set its FY 2026 guidance at 1.340-1.410 EPS. Research analysts forecast that The Pennant Group, Inc. will post 1.18 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on PNTG. Weiss Ratings raised shares of The Pennant Group from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, August 19th. Truist Financial lifted their price target on The Pennant Group from $42.00 to $48.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Royal Bank Of Canada lifted their price target on The Pennant Group from $42.00 to $44.00 and gave the company an “outperform” rating in a research note on Thursday, August 20th. Finally, Wells Fargo & Company boosted their price target on The Pennant Group from $45.00 to $46.00 and gave the company an “overweight” rating in a report on Tuesday, August 11th. Six investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $42.00.

Get Our Latest Analysis on The Pennant Group

About The Pennant Group

(Free Report)

The Pennant Group, Inc is a healthcare services company that operates home health, hospice and senior living businesses in the United States. Through its affiliated agencies and communities, the company provides skilled nursing, physical, occupational and speech therapy, personal care, hospice and palliative services, assisted living, and other support for older adults and individuals recovering from illness or injury.

Pennant’s home health and hospice operations serve patients in their homes and other residential settings, while its senior living segment operates communities that provide assisted living and related services.